@article{d6b6e71b81604e79a3f7c241ad7d8ba5,
title = "MRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology",
abstract = "Radiation therapy (RT) continues to be one of the mainstays of cancer treatment. Considerable efforts have been recently devoted to integrating MRI into clinical RT planning and monitoring. This integration, known as MRI-guided RT, has been motivated by the superior soft-tissue contrast, organ motion visualization, and ability to monitor tumor and tissue physiologic changes provided by MRI compared with CT. Offline MRI is already used for treatment planning at many institutions. Furthermore, MRI-guided linear accelerator systems, allowing use of MRI during treatment, enable improved adaptation to anatomic changes between RT fractions compared with CT guidance. Efforts are underway to develop real-time MRI-guided intrafraction adaptive RT of tumors affected by motion and MRI-derived biomarkers to monitor treatment response and potentially adapt treatment to physiologic changes. These developments in MRI guidance provide the basis for a paradigm change in treatment planning, monitoring, and adaptation. Key challenges to advancing MRI-guided RT include real-time volumetric anatomic imaging, addressing image distortion because of magnetic field inhomogeneities, reproducible quantitative imaging across different MRI systems, and biologic validation of quantitative imaging. This review describes emerging innovations in offline and online MRI-guided RT, exciting opportunities they offer for advancing research and clinical care, hurdles to be overcome, and the need for multidisciplinary collaboration. (C) RSNA, 2020",
keywords = "accuracy, combination, delineation, head, hypoxia, magnetic-field, neck-cancer, proton, radiotherapy, reconstruction, HEAD, RECONSTRUCTION, PROTON, HYPOXIA, COMBINATION, NECK-CANCER, ACCURACY, DELINEATION, MAGNETIC-FIELD, RADIOTHERAPY",
author = "R. Otazo and P. Lambin and J.P. Pignol and M.E. Ladd and H.P. Schlemmer and M. Baumann and H. Hricak",
note = "Funding Information: R.O. and H.H. supported by the National Institutes of Health/National Cancer Institute (P30 CA008748). Funding Information: Disclosures of Conflicts of Interest: R.O. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed patent issued for GRASP technique and patent filed for MRSIGMA. Other relationships: disclosed no relevant relationships. P.L. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed board memberships from Oncoradiomics SA, Convert Pharmaceuticals SA; consultancies from Benelux Health Ventures, ptTheragnostic-DNAmito, Convert Pharmaceuticals; grants/grants pending from Eurostars, the European Program SCANnTREAT, EuCanImage, Chaimeleon, Auto.Distinct, and NOW (Strategy); payments for lectures from Varian, Elekta; patents planned, pending, or issued; royalties from PCT/EP2014/059089; stock/stock options from Convert pharmaceuticals, the Medical Cloud Company, and Oncoradiomics; travel/accommodations/meeting expenses from Health Innovation Ventures; author discloses being a Licensee for Oncoradiomics. Other relationships: disclosed no relevant relationships. J.P.P. disclosed no relevant relationships. M.E.L. disclosed no relevant relationships. H.P.S. Activities related to the present article: disclosed grant from the large-scale equipment initiative of the German Research Council. Activities not related to the present article: disclosed payment for lectures from Siemens Health-ineers, Bayer Healthcare; disclosed travel/accommodations/meeting expenses from Siemens Healthineers, Bayer Healthcare. Other relationships: disclosed no relevant relationships. M.B. Activities related to the present article: disclosed board membership from Merck; disclosed consultancy from HI-STEM (Heidelberge). Activities not related to the present article: disclosed grants/funding for research from Teu-topharma, IBA, Bayer, Merck, Medipan; disclosed patents for DKFZ-PSMA617, Publisher Copyright: {\textcopyright} RSNA, 2020.",
year = "2021",
month = feb,
day = "1",
doi = "10.1148/radiol.2020202747",
language = "English",
volume = "298",
pages = "248--260",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America, Inc.",
number = "2",
}